Pfizer (PFE) stock has attracted fresh attention after recent trading left its one-month return at a 3.3% decline and its ...
Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...
Pfizer's 2026 revenue midpoint of $61B and EPS midpoint of $2.90 decline YoY, reflecting persisting headwinds. Read more on ...
8don MSN
2 Predictions for Pfizer in 2026
Pfizer recently announced its guidance for 2026. One thing seems clear: Its financial results won't get much stronger. It ...
Pfizer enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution. Click here to read ...
One reason why many investors could be asking this question is Pfizer's high dividend payout ratio of 99.4%. This metric ...
Investing $12,000 in the stock today would allow you to collect approximately $600 in dividends per year. Combined with the ...
Pfizer Inc. (NYSE:PFE) ranks among the best stocks under $25 to buy now. Citing the company’s cautious 2026 outlook, BMO ...
Its March 20 $29 put had the highest unusual options activity on the day with a Vol/OI (volume-to-open-interest) ratio of 210 ...
The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...
Diversification is key to successful long-term investing. In other words, don't put all your eggs in one basket.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback